Blocking lncRNA-SNHG16 sensitizes gastric cancer cells to 5-Fu through targeting the miR-506-3p-PTBP1-mediated glucose metabolism
Abstract Background Gastric cancer (GC) is a commonly occurring human malignancy. The 5-fluorouracil (5-Fu) is a first-line anti-gastric cancer agent. However, a large number of GC patients developed 5-Fu resistance. Currently, the roles and molecular mechanisms of the lncRNA-SNHG16-modulated 5-Fu r...
Main Authors: | Yan Ding, Sujie Gao, Jiabin Zheng, Xuebo Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | Cancer & Metabolism |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40170-022-00293-w |
Similar Items
-
LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement
by: Cong Zhang, et al.
Published: (2023-09-01) -
LncRNA SNHG1: role in tumorigenesis of multiple human cancers
by: Huang Zeng, et al.
Published: (2023-09-01) -
Silencing LncRNA SNHG16 suppresses the diabetic inflammatory response by targeting the miR-212-3p/NF-κB signaling pathway
by: Linjuan Huang, et al.
Published: (2023-06-01) -
LncRNA SNHG6 role in clinicopathological parameters in cancers
by: Khushbukhat Khan, et al.
Published: (2023-09-01) -
LncRNA SNHG1 knockdown inhibits hyperglycemia induced ferroptosis via miR‐16‐5p/ACSL4 axis to alleviate diabetic nephropathy
by: Xiangdong Fang, et al.
Published: (2023-09-01)